A groundbreaking human trial in Japan is exploring a revolutionary treatment to regrow teeth. Researchers have identified a way to activate...

Johnson & Johnson said on Thursday the U.S. Food and Drug Administration had approved its antibody-based therapy for patients with a diffic...

Based on pseudovirus and extensive pharmacokinetic data, the company said it believed the 500 mg dose of sotrovimab is sufficient to retain...

The treatment, an antibody therapy called AZD7442, had reduced the risk of people developing any COVID-19 symptoms by 77% in a late-stage t...

The new antibody attaches to a part of the virus that differs little across the variants, meaning that it is unlikely for resistance to ari...

"ADG20, a novel monoclonal antibody targeting the spike protein of SARS-CoV-2 and related coronaviruses, is in global clinical development ...

The only Indian company Zydus Cadila which claims to have developed neutralising monoclonal antibodies (mAbs)-based cocktail for the treatm...

As part of this single dose infusion-based treatment, patients with mild to moderate symptoms, are offered a cocktail of Casirivimab and Im...

As part of this single dose infusion-based treatment, patients with mild to moderate symptoms are offered a cocktail of Casirivimab and Imd...

"This is worrisome because the rapid spread of variants that might not be efficiently inhibited by antibodies could undermine our current v...

In an "Evidence Based Advisory to address Inappropriate Use of Convalescent Plasma in COVID-19 Patients", the Indian Council of Medical Res...

Antibodies from animals have been used to control many viral and bacterial infections such as rabies, hepatitis B, vaccine virus, tetanus, ...

The therapy works like plasma therapy. However, the blood plasma is obtained from animals — from horses, in this case — that have recovered...

More recently, scientists have developed treatments called monoclonal antibodies -- antibodies that can be isolated and manufactured in lar...

We are working to repurpose our novel monoclonal antibody Itolizumab (used in psoriasis) to treat complications caused by Covid-19 infectio...

The ICMR has asked research institutions including hospitals to participate in the funding round and it expects research activities to take...

The Thiruvananthapuram-based institute, which is an institute of national importance under the Department of Science and Technology, receiv...